Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9576-4
Annals of Surgical Oncology 14:3321-3327 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilimoria, K. Y.
Right arrow Articles by Bentrem, D. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bilimoria, K. Y.
Right arrow Articles by Bentrem, D. J.

Original Article

Impact of Adjuvant Radiation on Survival: A Note of Caution When Using Cancer Registry Data to Evaluate Adjuvant Treatments

Karl Y. Bilimoria, MD1,2, Andrew K. Stewart, MA2, James S. Tomlinson, MD3, E. Greer Gay, RN, PhD2, Clifford Y. Ko, MD, MS, MSHS2,3, Mark S. Talamonti, MD1 and David J. Bentrem, MD1

1 Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
2 Cancer Programs, American College Surgeons, Chicago, Illinois, USA
3 Department of Surgery, University of California, Los Angeles (UCLA) and VA Greater Los Angeles Healthcare System, Los Angeles, California, USA

Correspondence: Address correspondence and reprint requests to: David J. Bentrem, MD; E-mail: dbentrem{at}nmff.org

Background: With increasing frequency, studies using cancer registries have evaluated the treatment effect of adjuvant radiation; however, these analyses generally do not include chemotherapy treatment data. Our objective is to evaluate the potential impact the absence of adjuvant chemotherapy data has on the estimated survival benefit attributed to adjuvant radiation therapy.

Methods: Using the National Cancer Data Base, patients were identified who underwent surgery for cancers that often require radiation therapy: breast, esophageal, gastric, pancreatic, and rectal cancer. Cox proportional hazards modeling with and without chemotherapy as a predictor variable was used to assess the impact of radiation therapy on 5-year survival.

Results: From 1998 to 1999, 295,206 patients underwent surgical resection for one of five cancers. Chemotherapy administration ranged from 27.5% for gastric to 56.1% for rectal cancer. For cancers where chemotherapy affected survival, the impact of radiation therapy was overestimated in the multivariate model when chemotherapy was not included. For example, radiation treatment for rectal cancer was associated with a 31% decrease in the risk of death in the model that did not control for chemotherapy; however, the addition of chemotherapy to the model resulted in only a 14% decrease in the risk of death associated with receiving radiation therapy.

Conclusions: For selected tumor sites, the administration of chemotherapy is not evenly distributed among patients receiving and not receiving radiation. Survival analyses that do not include chemotherapy administration overestimate the beneficial impact of radiation on survival. Evaluating the effect of radiation on survival retrospectively without adjusting for chemotherapy administration should be done cautiously.

Key Words: Survival • Radiation • Chemotherapy • National Cancer Data Base • SEER • Adjuvant therapy • Chemoradiation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.